Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
IRIDEX CORP reported the three months ended December 31, 2022 results: revenue $15.2 million, net income $1.1 million, EPS $0.07 per share.
- Period
- the three months ended December 31, 2022
- Revenue
- $15.2 million
- Net income
- $1.1 million
- EPS
- $0.07 per share
- Result
- reported results
Exact text from the filing
results for the fourth quarter and year ended December 31, 2022 and issued 2023 financial guidance. Fourth Quarter 2022 & Recent Highlights • Generated total revenue of $15.2 million, essentially unchanged from the prior year period • Cyclo G6® product family revenue of $4.2 million, an increase of 9% year-over-year o 16,400 Cyclo G6 probes sold, a quarterly
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
IRIDEX CORP reported full year 2023 results: revenue $57 million to $59 million. Guidance initiated.
- Period
- full year 2023
- Revenue
- $57 million to $59 million
- Guidance
- initiated
- Result
- guidance update
Exact text from the filing
Total revenue for the full year is expected to be $57 million to $59 million.
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
IRIDEX CORP reported the year ended December 31, 2022 results: revenue $57.0 million, net income $7.5 million, EPS $0.47 per share.
- Period
- the year ended December 31, 2022
- Revenue
- $57.0 million
- Net income
- $7.5 million
- EPS
- $0.47 per share
- Result
- reported results
Exact text from the filing
577 systems in February 2023 • Cash and cash equivalents totaled approximately $13.9 million as of December 31, 2022 Full Year 2022 Highlights • Generated total revenue of $57.0 million, an increase of 6% compared to 2021 • Cyclo G6 product family revenue of $14.7 million, an increase of 5% year-over-year • Sold 59,800 Cyclo G6 probes, compared to 58,200 in the
View on SEC.gov